IRIS
BOCCHIO CHIAVETTO, LUISELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.959
EU - Europa 3.280
AS - Asia 1.041
AF - Africa 242
Continente sconosciuto - Info sul continente non disponibili 22
SA - Sud America 16
OC - Oceania 3
Totale 12.563
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.851
DE - Germania 1.446
CN - Cina 721
UA - Ucraina 607
RU - Federazione Russa 291
SE - Svezia 281
CM - Camerun 236
GB - Regno Unito 200
SG - Singapore 185
FI - Finlandia 130
CA - Canada 107
IE - Irlanda 93
TR - Turchia 84
IT - Italia 75
FR - Francia 70
PL - Polonia 66
EU - Europa 22
IN - India 10
IL - Israele 8
IR - Iran 5
PE - Perù 5
VN - Vietnam 5
BR - Brasile 4
HU - Ungheria 4
ID - Indonesia 4
BE - Belgio 3
AM - Armenia 2
AR - Argentina 2
AU - Australia 2
EC - Ecuador 2
ES - Italia 2
HK - Hong Kong 2
KZ - Kazakistan 2
MA - Marocco 2
MY - Malesia 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
LT - Lituania 1
LY - Libia 1
MN - Mongolia 1
MX - Messico 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 12.563
Salva come PNG Salva come JPEG
Città #
Fairfield 1.564
Woodbridge 699
Seattle 694
Ashburn 675
Houston 660
Beijing 636
Cambridge 604
Jacksonville 559
Chandler 539
Wilmington 504
Ann Arbor 213
Ottawa 104
Boardman 103
Dublin 90
Lawrence 90
Princeton 86
New York 70
Singapore 68
Kraków 65
Helsinki 62
San Diego 49
London 45
Saint Petersburg 35
Nanjing 17
Los Angeles 16
Norwalk 16
Prescot 16
Cedar Knolls 13
Kunming 13
Redwood City 13
Chiswick 12
Guangzhou 12
Hefei 9
Islington 9
Kilburn 9
Dearborn 8
Milan 8
Falls Church 7
Hounslow 7
Mcallen 7
Chengdu 5
Nanchang 5
Redmond 5
St Louis 5
Hanoi 4
New Bedfont 4
West Jordan 4
Atlanta 3
Brussels 3
Chicago 3
Jinan 3
Kocaeli 3
Rimini 3
Segrate 3
Shanghai 3
Shenyang 3
Sotto 3
Almaty 2
Behshahr 2
Garden City 2
Hanover 2
Istanbul 2
Lake Forest 2
Miami Beach 2
Novara 2
Palermo 2
Rio de Janeiro 2
San Francisco 2
Serrata 2
Wuhan 2
Yerevan 2
Abu Dhabi 1
Acton 1
Ampang 1
Andover 1
Ankara 1
Bandar 1
Bareggio 1
Baronissi 1
Bergamo 1
Brescia 1
Brisbane 1
Bristol 1
Cardiff 1
Changsha 1
Chesapeake 1
Chongqing 1
Dallas 1
Delta 1
Fernando De La Mora 1
Focsani 1
Fuzhou 1
Fácánkert 1
Groningen 1
Guayaquil 1
Hamilton 1
Hebei 1
Hong Kong 1
Hospozin 1
Islamabad 1
Totale 8.525
Salva come PNG Salva come JPEG
Nome #
The -1727 A/T, -50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms and resistance to antipsychotics in schizophrenia 380
Immune and metabolic alterations in first episode psychosis (FEP) patients 325
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 258
Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients 233
Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis 232
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 228
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects 219
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 206
Allelic variation in the human prodynorphin gene promoter and schizophrenia 202
Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease 197
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. 196
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients 192
Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: A case-control study 184
Aspetti biologici e neuropsicologici del maltrattamento e abuso infantili 184
Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease 182
Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia 182
Effetti biomolecolari del maltrattamento infantile: il ruolo dell'epigenetica e dell'infiammazione 182
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses 181
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 176
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study 175
Nanomedicine in Psychiatry: New Therapeutic Opportunities from Research on Small RNAs 175
Serum Levels of Insulin-Like Growth Factor-1 and Obsessive-Compulsive Disorder: A Case-Control Study 175
BDNF Val66Met polymorphism and protein levels in Amniotic Fluid 172
Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor 170
Season of birth and inflammatory response system in schizophrenia 169
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients 169
Influence of serotonin receptor 2A His452Tyr polymorphism on brain temporal structures: a volumetric MR study 168
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 168
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 167
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence 167
Effects of Intranasal Oxytocin on Long-Term Memory in Healthy Humans: A Systematic Review 166
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 165
Markers of Alzheimer's disease in a population attending a memory clinic 164
Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients 164
Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16 164
Glucose metabolism alterations in patients with bipolar disorder 164
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 160
Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter 158
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 158
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics 157
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 157
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment 157
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients 157
Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia 156
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 155
G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 154
Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults. 154
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 152
VEGF serum levels in depressed patients during SSRI antidepressant treatment 152
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers 150
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial 150
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease 149
Blood microRNA changes in depressed patients during antidepressant treatment 148
Blood microRNA longitudinal changes in depressed patients during antidepressant treatment 146
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 144
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 143
Lack of association between MnSOD gene polymorphism and sporadic Alzheimer's disease 142
Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases 134
Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum. 133
No occurrence of the glutamate transporter EAAT2 A206G polymorphism in schizophrenic subjects 131
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 106
Association study of-1727 A/T,-50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms with schizophrenia 105
Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants 105
CYP2D6 polymorphism in patients with Alzheimer's disease in treatment with cholinesterase inhibitors 104
Gene-environment interaction in major depression: focus on experience-dependent biological systems 101
Influence of G1730A polymorphism of estrogen receptor beta gene on brain morphology in postmenopausal women 100
Peripheral BDNF levels and personality traits in a sample of subjects non affected by psychiatric diseases 97
Evidence in Support of the AD Biomarker Dynamic Model from a Memory Clinic Naturalistic Series of Patients with Mild Cognitive Impairment 93
The cytokine network genes and resistance to antipsychotics in schizophrenia 92
Serum and plasma BDNF levels in major depression: Replication study plus meta-analysis 91
Brain-derived neurotrophic factor as potential diagnostic biochemical marker of depressive state 91
Association between IL-1 cluster and IL-10 gene polymorphisms and schizophrenia 90
Association study between -1727A/T, -50C/T and (CAA)(N) repeat GSK-3beta gene polymorphisms and Bipolar Disorder 89
Association study and meta-analysis of-308 A/G functional polymorphism in TNF alpha gene with schizophrenia 89
Association between IL-1 beta-511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia 88
Serum brain derived neurotrophic factor concentrations in attention deficit hyperactivity disorder (ADHD) 87
Molecular mechanisms of brain stimulation. (Chapter 11). 82
Plasma Aβ42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study 79
Myeloid microvesicles in CSF are associated with myelin damage and neuronal loss in mild cognitive impairment and alzheimer disease. 76
Childhood trauma and glucose metabolism in patients with first-episode psychosis 76
miR-146a Plasma Levels Are Not Altered in Alzheimer's Disease but Correlate With Age and Illness Severity 68
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response 55
Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles 40
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 30
A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup. 24
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations 19
Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients 17
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 14
null 5
null 2
null 1
null 1
null 1
Totale 12.716
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.161
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.290 0 0 0 0 386 292 199 264 183 594 254 118
2020/20212.814 322 294 248 400 288 243 322 142 125 116 247 67
2021/2022598 108 59 128 46 9 21 21 139 33 23 8 3
2022/20231.614 176 11 11 221 167 344 1 230 299 43 87 24
2023/2024558 27 40 62 68 59 86 21 10 0 16 5 164
2024/2025135 34 22 15 3 61 0 0 0 0 0 0 0
Totale 12.716